Osteosarcoma Cells and Undifferentiated Human Mesenchymal Stromal Cells Are More Susceptible to Ferroptosis than Differentiated Human Mesenchymal Stromal Cells

Current research suggests that promoting ferroptosis, a non-apoptotic form of cell death, may be an effective therapy for osteosarcoma, while its inhibition could facilitate bone regeneration and prevent osteoporosis. Our objective was to investigate whether the susceptibility to and regulation of f...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Yuliya D. Smirnova, Dominik Hanetseder, Lukas Derigo, Andreas Sebastian Gasser, Annette Vaglio-Garro, Simon Sperger, Regina Brunauer, Olga S. Korneeva, Johanna Catharina Duvigneau, Darja Marolt Presen, Andrey V. Kozlov
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	MDPI AG 2025-02-01
Sarja:	Antioxidants
Aiheet:	ferroptosis osteosarcoma Erastin RSL3 Ferrostatin-1
Linkit:	https://www.mdpi.com/2076-3921/14/2/189
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!